Second look Holter ECG in neurorehabilitation
-
Published:2019-12
Issue:1
Volume:1
Page:
-
ISSN:2524-3489
-
Container-title:Neurological Research and Practice
-
language:en
-
Short-container-title:Neurol. Res. Pract.
Author:
Knecht StefanORCID, Petsch Sebastian, Kirchhof Paulus, Studer Bettina
Abstract
Abstract
Background
Many stroke survivors suffer recurrent stroke because paroxysmal atrial fibrillation (AF) was missed and no preventive anticoagulation initiated. This prospective cohort study determined the added diagnostic yield of second-look 24-h electrocardiographic recording (ECG) in a population at high risk for AF: patients who suffered a stroke of such severity that they require inpatient neurorehabilitation.
Methods
We enrolled 508 patients with ischemic stroke admitted to post-acute inpatient neurorehabilitation and determined whether AF was detected during acute care at the referring hospital. Second-look baseline and 24-h Holter ECG were then conducted during neurorehabilitation. Primary outcome was number of newly detected AF with duration of > 30 s; secondary outcomes were number of newly detected absolute arrhythmia of 10–30 s and < 10 s duration. For comparison, we further enrolled 100 patients with hemorrhagic stroke without history of AF (age = 72 + 11 years, 51% female).
Results
In 206 of the 508 ischemic stroke patients, AF had been detected during acute phase work-up (age = 78 + 10 years, 55% female). For the remaining 302 ischemic stroke patients, no AF was detected during acute phase work-up (age = 74 + 9 years; 47% female). Second-look 24-h ECG showed previously missed AF of > 30 s in 20 of these patients, i.e. 6.6% of the sample, and shorter absolute arrhythmia in 50 patients (i.e. 16.5%).
Conclusions
Second-look 24-Hour ECG performed during post-acute inpatient neurorehabilitation has a high diagnostic yield and should become a standard component of recurrent stroke prevention.
Publisher
Springer Science and Business Media LLC
Subject
Automotive Engineering
Reference35 articles.
1. Hart, R. G., Diener, H.-C., Coutts, S. B., Easton, J. D., Granger, C. B., O’Donnell, M. J., et al. (2014). Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol, 13, 429–438. 2. Hart, R. G., Sharma, M., Mundl, H., Kasner, S. E., Bangdiwala, S. I., Berkowitz, S. D., et al. (2018). Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med, 378, 2191–2201. https://doi.org/10.1056/NEJMoa1802686. 3. Diener, H.-C., Sacco, R. L., Easton, J. D., Granger, C. B., Bernstein, R. A., Uchiyama, S., et al. (2019). Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med, 380, 1906–1917. https://doi.org/10.1056/NEJMoa1813959. 4. Rabinstein, A. A. (2014). Prolonged cardiac monitoring for detection of paroxysmal atrial fibrillation after cerebral ischemia. Stroke, 45, 1208–1214. https://doi.org/10.1161/STROKEAHA.113.003389. 5. Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., JJB, C., Demaerschalk, B. M., et al. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44, 870–947.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|